Roundup lawsuit: Jury in glyphosate-cancer case awards plaintiff $81 million

b a o

A U.S. jury on [March 27] awarded $81 million to a man who claimed his use of Bayer AG’s glyphosate-based weedkiller Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits.

unnamed file
Plaintiff Edwin Hardeman, right. Image: Jeff Chiu/AP

The jury in San Francisco federal court said the company was liable for plaintiff Edwin Hardeman’s non-Hodgkin’s lymphoma. It awarded $5.9 million in compensatory and $75 million in punitive damages to Hardeman after finding that Roundup was defectively designed, that Monsanto failed to warn of the herbicide’s cancer risk and that the company acted negligently.

The verdict comes….after the same jury on March 19 found Roundup to have been a “substantial factor” in causing Hardeman’s cancer….Bayer shares fell more than 12 percent after last week’s jury finding.

ADVERTISEMENT

In a statement released after the verdict, Bayer said….”This verdict does not change the weight of over four decades of extensive science and the conclusions of regulators worldwide that support the safety of our glyphosate-based herbicides and that they are not carcinogenic….Bayer will appeal this verdict.”

Related article:  Viewpoint: North American scientists, IARC officials conspired to misrepresent glyphosate health risks

Read full, original article: U.S. jury says Bayer must pay $81 million to man in Roundup cancer trial

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend